MOLIPAXIN

This brand name is authorized in Ireland, Malta, United Kingdom, South Africa

Active ingredients

The drug MOLIPAXIN contains one active pharmaceutical ingredient (API):

1 Trazodone
UNII 6E8ZO8LRNM - TRAZODONE HYDROCHLORIDE

Trazodone is a potent antidepressant. It also has anxiety reducing activity. Trazodone is a triazolopyridine derivative chemically unrelated to known tricyclic, tetracyclic and other antidepressant agents. It has negligible effect on noradrenaline re-uptake mechanisms.

Read about Trazodone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MOLIPAXIN Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N06AX05 Trazodone N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 15911, 15918, 23966
Country: IE Health Products Regulatory Authority Identifier(s): 33197, 33251, 33294
Country: MT Medicines Authority Identifier(s): AA1173/06001, AA1173/06002, AA1173/06003
Country: ZA Health Products Regulatory Authority Identifier(s): E/1.2/10, E/1.2/9

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.